Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2003

Hay Rick V, Cao Brian, Skinner R Scot, Wang Ling-Mei, Su Yanli, Resau James H, Knudsen Beatrice S, Gustafson Margaret F, Koo Han-Mo, Vande Woude George F, Gross Milton D

Abstract excerpt

PURPOSE: Inappropriate expression of the receptor tyrosine kinase Met and its ligand is associated with an aggressive phenotype and poor clinical prognosis for a wide variety of solid human tumors. We are developing imaging and therapeutic agents that target this receptor-ligand complex. In this study, we evaluated the ability of radioiodinated anti-Met monoclonal antibodies from a single hybridoma clone to image...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mice, Nude
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Separation

Share to Flow Cytometry

Share to Hybridomas

Share to Ligands

Share to Neoplasm Transplantation

Share to Proto-Oncogene Proteins c-met

Source

Identifiers

PMID: 14506181

Genes

HGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody.PMID 14506181Read ↗

MET: a critical player in tumorigenesis and therapeutic target.Semantic proximity Read ↗

In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.Semantic proximity Read ↗

Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.Semantic proximity Read ↗

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.Semantic proximity Read ↗

Tumorigenicity of the <i>met</i> Proto-Oncogene and the Gene for Hepatocyte Growth FactorSemantic proximity Read ↗

Four individually druggable MET hotspots mediate HGF-driven tumor progressionSemantic proximity Read ↗

C-Met Autocrine Activation Induces Development Of Malignant Melanoma And Acquisition Of The Metastatic PhenotypeSemantic proximity Read ↗

Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.Semantic proximity Read ↗

A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity.Semantic proximity Read ↗

A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts.Semantic proximity Read ↗

Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.Semantic proximity Read ↗

BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.